Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 23, 2024Blood AdvancesOpen Access

T-cell dysfunction in CLL is mediated through expression of SIGLEC-10 ligands CD24 and CD52 on CLL cells

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJaco A. C. van BruggenFPFleur S. PetersMMMorris Mes

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bruggen et al. (2024) studied this question.

synapsesocial.com/papers/68e5f50bb6db6435875899c7https://doi.org/10.1182/bloodadvances.2023011934
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The complexities of T-cell dysfunction in chronic lymphocytic leukemia2024 · 4 citations
  2. 2T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia2026
  3. 3Functional differences between CLL‐ and ALL‐derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL‐10 as potential modulatory targets2025 · 2 citations
  4. 4Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia2025 · 19 citations
  5. 5IL‑10 limits CLL progression by reprogramming T cell exhaustion and myeloid suppression2025